MedTrace Logo

Growth and Tolerance of Young Infants

NCT03276884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 267

Last updated 2018-12-03

No results posted yet for this study

Summary

To compare growth and tolerance of healthy term infants fed two amino acid-based infant formulas.

Conditions

  • Growth

Interventions

OTHER

Experimental Infant Formula

amino acid-based infant formula powder

OTHER

Control Infant Formula

amino acid-based infant formula powder

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Jan Kajzer, MS, RD, LD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
8 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-11
Primary Completion
2018-11-08
Completion
2018-11-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03276884 on ClinicalTrials.gov